You have 9 free searches left this month | for more free features.

Viral Protease Inhibitors

Showing 1 - 25 of 8,943

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HIV-1-infection, Multi-Antiviral Resistance Trial in Milan (REGISTER CREATION)

Recruiting
  • HIV-1-infection
  • Multi-Antiviral Resistance
  • REGISTER CREATION
  • Milan, MI, Italy
    Ospedale San Raffaele
Dec 22, 2021

COVID-19 Trial in Minneapolis (Shionogi Protease Inhibitor (S-217622), )

Recruiting
  • COVID-19
  • Shionogi Protease Inhibitor (S-217622)
  • placebo
  • Minneapolis, Minnesota
    University of Minnesota
Jan 12, 2023

Protease Inhibitors in Chronic Hepatitis C

Completed
  • Chronic Hepatitis C
    • Graz, Austria
      Department of Internal Medicine, Medical University of Graz
    Jan 11, 2023

    HIV-1 Infection Trial (Doravirine, Tenofovir, Lamivudine, Baseline regimen of ritonavir- or cobicistat-boosted protease

    Active, not recruiting
    • HIV-1 Infection
    • Doravirine, Tenofovir, Lamivudine
    • +4 more
    • (no location specified)
    Sep 2, 2022

    Metastatic Melanoma, Immune Checkpoints Inhibitors, Gastrointestinal Microbiome (Bacterial and Viral) Trial in Ljubljana (Immune

    Recruiting
    • Metastatic Melanoma
    • +3 more
    • Immune checkpoint inhibitor
    • Ljubljana, Slovenia
      Institute of Oncology Ljubljana
    May 17, 2023

    HIV-1-infection Trial in Kenya (Dolutegravir)

    Completed
    • HIV-1-infection
    • Kiambu, Kenya
    • +3 more
    Jan 26, 2022

    HIV Trial in United States (Ritonavir, Saquinavir, Methadone HCl)

    Completed
    • HIV Infections
    • San Francisco, California
    • +6 more
    Oct 27, 2021

    HIV Trial in United States (Pravastatin sodium, Simvastatin, Atorvastatin calcium)

    Completed
    • HIV Infections
    • Pravastatin sodium
    • +5 more
    • Los Angeles, California
    • +12 more
    Oct 27, 2021

    HIV Patients Trial in France (No intervention)

    Completed
    • HIV Patients
    • No intervention
    • Créteil, France
    • +5 more
    Jul 30, 2021

    HIV, Cardiovascular Diseases, Hypertension Trial in United States (Indinavir sulfate, Ritonavir, Amlodipine)

    Completed
    • HIV Infections
    • +2 more
    • Indinavir sulfate
    • +3 more
    • San Francisco, California
    • +8 more
    Oct 28, 2021

    HIV-1 Infection Trial in Badalona (Isentress® (Raltegravir, 400 mg every 12 hours), Isentress® (Raltegravir, 400 every 12

    Completed
    • HIV-1 Infection
    • Isentress® (Raltegravir, 400 mg every 12 hours)
    • Isentress® (Raltegravir, 400 every 12 hours)
    • Badalona, Barcelona, Spain
      Germans Trias i Pujol Hospital
    Nov 11, 2019

    HIV Trial in United States (Fosamprenavir, Lopinavir/Ritonavir, Ritonavir)

    Completed
    • HIV Infections
    • Los Angeles, California
    • +12 more
    Oct 28, 2021

    HIV Trial in Puerto Rico, United States (Tamoxifen, Vorinostat, Antiretroviral drugs)

    Active, not recruiting
    • HIV Infections
    • Birmingham, Alabama
    • +13 more
    Jan 13, 2022

    HIV Trial in United States (Lopinavir/Ritonavir, Abacavir sulfate, Nevirapine)

    Completed
    • HIV Infections
    • Los Angeles, California
    • +22 more
    Oct 28, 2021

    HIV I Infection, Adiposity Trial in Saint Louis (Frequently sampled glucose tolerance testing, abdominal subcutaneous adipose

    Recruiting
    • HIV I Infection
    • Adiposity
    • Frequently sampled glucose tolerance testing
    • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jun 15, 2022

    HIV Trial in United States (Ritonavir, Nelfinavir mesylate, Levocarnitine)

    Completed
    • HIV Infections
    • Birmingham, Alabama
    • +44 more
    Oct 27, 2021

    Kidney Transplantation, Cytomegalovirus Infections Trial in L'Hospitalet de Llobregat (Switch from Mycophenolate Mofetil to

    Not yet recruiting
    • Kidney Transplantation
    • Cytomegalovirus Infections
    • Switch from Mycophenolate Mofetil to Everolimus manteinance treatment in Active Comparator Arm
    • no intervention
    • L'Hospitalet de Llobregat, Barcelona, Spain
      Hospital Universitari de Bellvitge
    Jun 16, 2021

    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Coronavirus Disease 2019 (COVID-19), Immunocompromised Trial

    Not yet recruiting
    • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
    • +4 more
    • Cooperstown, New York
    • +10 more
    Dec 11, 2022

    HIV, Pregnancy Trial in Worldwide (Lamivudine, Lamivudine/Zidovudine, Nelfinavir mesylate)

    Completed
    • HIV Infections
    • Pregnancy
    • Los Angeles, California
    • +48 more
    Oct 28, 2021

    HIV Trial in United States (Hydroxyurea, Efavirenz, Stavudine)

    Completed
    • HIV Infections
    • Menlo Park, California
    • +18 more
    Oct 27, 2021

    HIV Trial in United States (Indinavir sulfate, Saquinavir)

    Completed
    • HIV Infections
    • Palo Alto, California
    • +15 more
    Oct 27, 2021

    HIV Trial in Canada, United States (Indinavir sulfate, Ritonavir, Nelfinavir mesylate)

    Completed
    • HIV Infections
    • Indinavir sulfate
    • +2 more
    • San Francisco, California
    • +43 more
    Oct 27, 2021

    HIV Trial in United States (Indinavir sulfate, Ritonavir, Nelfinavir mesylate)

    Completed
    • HIV Infections
    • Indinavir sulfate
    • +3 more
    • San Francisco, California
    • +14 more
    Oct 27, 2021

    HIV/AIDS Trial in Worldwide (Biktarvy, Symtuza)

    Recruiting
    • HIV/AIDS
    • Antwerp, Belgium
    • +47 more
    Jan 9, 2023